Download Surgery for Anal Cancer

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Surgery for Anal Cancer
Peter Sagar
The General Infirmary at Leeds
Where is the anal canal?
• Perianal cancer
• Anal canal cancer
Anal canal
Perianal neoplasms
• Perianal skin – junction of the hair-bearing
skin and anoderm of the anal canal
Perianal neoplasms
•
•
•
•
Squamous cell carcinoma
Basal cell carcinoma
Bowen’s disease
Perianal Paget’s disease
Squamous cell carcinoma
•
•
•
•
•
Rolled everted edges
Central ulceration
Late diagnosis
30% misdiagnosed
Spread to lymph
nodes
Perianal squamous cell carcinoma
- treatment
• Wide local excision – well differentiated,
up to 3 cm
• Less favourable lesions- chemoradiation
(40-70 Gy)
Perianal basal cell carcinoma
•
•
•
•
•
•
Uncommon
1-2 cm
Rarely metastasize
Misdiagnosed in 33%
Delayed diagnosis
Rx – local excision
with adequate
margins
Bowen’s disease
• Intraepidermal
squamous cell
carcinoma
• Associated with
primary internal
malignancies (5%)
• Discrete scaly or
crusted plaques
Bowen’s disease
- mapping biopsies
Bowen’s disease
- excise deep to subcutaneous fat
Perianal Paget’s disease
• Extramammary
Paget’s found in axilla
and anogenital region
• Uncommon
• Eczematous lesions
• Visceral carcinomas
in 50%
Perianal Paget’s disease
- biopsy & identify Paget’s cells
Perianal Paget’s disease
-
Excise deep to subcutaneous fat &
up to dentate line
Outline of flaps
Arrowhead flaps
Flaps sutured to anal canal
Y shaped flaps at completion
Squamous cell carcinoma of the
anal canal
• Long h/o minor
perianal symptoms
• 33% misdiagnosed
• Assess primary lesion
• Examine groins
• Proctoscopy
• Endoanal ultrasound
• MRI
Squamous cell carcinoma of the
anal canal
• Spread determined by
dentate line
• 20% nodal
involvement at
presentation
• Extensive Ca may
invade muscular/bony
walls of the pelvis
Squamous cell cancer
- treatment
• Local excision
• CHEMORADIATION
• Abdominoperineal
resection
Inguinal lymph node
• No indication for prophylactic groin
dissection
• Ominous sign if present at presentation
• Rx chemoradiation to groin nodes
Patient Numbers
Total Number of Patients
188
Not treated with XRT
Treated with XRT
13
175
50Gy
110
49.9-30.1Gy
9
30Gy
<30Gy
39
17
Clinical Stage - primary
50
45
40
35
30
No 25
20
15
10
5
0
T1
T2
T3
Stage
T4
Clinical stage - nodes
80
70
60
50
No 40
30
20
10
0
N0-1
N2-3
Nodal stage
Patterns of failure
14
12
10
8
6
4
2
0
Local
Distant
Both
TIME TO LOCAL FAILURE
14
12
10
8
6
4
2
0
3/12 - 6/12
6/12 - 12/12
> 1YR
Local control
1,1
1,0
,9
Local control
,8
,7
,6
,5
,4
,3
,2
,1
0,0
0
20
40
60
Time (months)
80
100
Overall survival
1,1
1,0
,9
,8
,7
,6
,5
,4
,3
,2
,1
0,0
0
20
40
60
Time (months)
80
100
Overall survival by stage
1,2
T1
1,0
,8
T2
T3
,6
T4
,4
,2
0,0
0
20
40
60
Time (months)
80
100
Local control by stage
1,1
1,0
,9
,8
,7
,6
,5
T4
,4
,3
,2
,1
0,0
0
20
40
60
Time (months)
80
100
Salvage Surgery
Treated to 50Gy
110
Local recurrence
23
Number had
salvage surgery
13/23
Alive and well
5
Dead disease
6
Dead other
2
Patterns of failure
• Anal area or regional lymph nodes
• APER for residual or recurrent carcinoma
• Fixed disease at time of Rx failure, median
survival = 8 mths
APER for local failure of treatment
• Not easy
Technical tips
• Fill the hole
• Tackle pelvic side wall involvement
• Sacral invasion
Rectus abdominus flap
Sidewall vessel involvement
vessels
Pelvic side wall
• BLEEDING
•
•
•
•
Suture
Fibrillar surgicell
Argon beamer
Be prepared to pack
Direct invasion of the sacrum
• Choose level of sacrectomy carefully
• Frozen section
• Beware bleeding from pre-sacral veins
APR+S vs TPE+S
Summary
• High index of suspicion
• Mapping biopsies (4 or 12 quadrants)
• Excision biopsy
• Failure of local treatment = referral to specialist
centre
Anorectal melanoma
• Depressing
• Third most common
site
• Confused with
thrombosed
haemorrhoid
• Spread submucosally
WLE vs APER
• 428 patients
• WLE n=90, APER n=189
• Free of disease at 5yrs:
– WLE = 8%
– APE = 13%